Gil Labrucherie

Gil Labrucherie serves as the Chief Financial Officer at Septerna since January 2025 and has been a Managing Trustee at Bloom Family Trust since October 2022, where responsibilities include managing commercial real estate assets and an investment portfolio. As a Board Member and Chair of the Audit Committee for Rezolute, Inc. since November 2018, Gil Labrucherie has also held various leadership positions, including Chief Financial Officer and Chief Business Officer at ACELYRIN, INC. from August 2023 to January 2025. Previously, Gil Labrucherie was Chief Operating Officer and Chief Financial Officer at Nektar Therapeutics, overseeing multiple teams and recognized for exceptional performance by the Board of Directors. Additional experience includes serving as a Board Member at Valinor Pharma until its sale in July 2024 and holding corporate development roles at E2open, Inc. and AltaVista Company. Educational credentials include a Juris Doctor from the University of California, Berkeley - School of Law and a Bachelor of Arts with Highest Honors from the University of California, Davis.